Researchers led by Michigan Technological University biologist Xiaoqing Tang found that the genetic material in question is a microRNA molecule called miR-30d, which is the same in mice and people.
MicroRNA, or miRNA, attaches to long RNA molecules and prevents them from making proteins.
Researchers found that the protein MAP4K4 blocks the formation of insulin when cells are under adverse conditions.
MAP4K4 interferes with the production of an important protein named MafA that binds to DNA and is an essential part of the insulin-making pathway.
In a series of experiments, Tang and her research team showed how miR-30d can counteract the tumour necrosis factor
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
